November 20, 2019 by matray

The Doctors Company announced today the promotion of longtime company executive Marco Vanderlaan to chief financial officer (CFO) and chief risk officer.

Vanderlaan has held a variety of senior leadership positions with The Doctors Company over 18 years. He most recently served as senior vice president, business assessment, a role he has held since 2010. He has also held executive positions in finance, reinsurance and strategic planning.

Vanderlaan succeeds David Preimesberger, who assumes new roles as senior vice president for strategic planning and chief ethics officer.

“I am pleased to welcome Marco to his new role,” said Richard E. Anderson, MD, FACP, chairman and chief executive officer of The Doctors Company. “He has demonstrated vision and foresight in mergers and acquisitions, enterprise risk management, internal audits and our ethics program, and has been instrumental in the growth of the Tribute Plan — an unrivaled financial benefit for our members. I am confident that expanding Marco’s role will help accelerate our next phase of growth as we meet the complex insurance, risk management and risk financing needs of physicians, large groups, hospitals and healthcare systems.”

“I am honored to take on this position and drive key priorities to build upon our market leadership position,” said Vanderlaan. “I look forward to growing the financial success, risk intelligence and conservative business philosophy that empowers our mission to advance, protect and reward the practice of good medicine.”